random comparison methotrex dose addit bleomycin chop therapi diffus larg cell lymphoma non-hodgkin lymphoma cancer leukemia group studi cancer leukemia group studi use addit bleomycin high-dos methotrex therapi treatment certain adult non-hodgkin lymphoma between patient diffus larg cell lymphoma dlcl patient intermediate-grad non-hodgkin lymphoma therapi cours cyclophosphamid adriamycin vincristin prednison chop week low-dos bleomycin continu IV infus respond cours week therapi high-dos methotrex leucovorin rescu standard-dos methotrex rescu therapi addit cours chop addit low-dos infus bleomycin use high-dos low-dos methotrex signific effect respons patient dlcl complet respons rate treatment program median failure-fre surviv ff entir group dlcl patient month ff signific effect ff addit low-dos bleomycin chop ff chop chop-b use differ dose methotrex ff high-dos standard-dos patient follicular larg cell lymphoma diffus area ff ff patient dlcl ff patient histopatholog subtyp diffus lymphoma ff ff 